Deploying artificial intelligence successfully in Europe requires an integrated landscape for its adoption, and its development based on Europe’s unique characteristics, write Edward Curry of NUI Galway and Barry O’Sullivan of University College Cork.

The interest in fullerenes lies in their unique energy levels and high electron affinity which makes these molecules promising candidates for biological applications such as carriers for drug and gene therapy, or pharmaceutical applications such as being used as carriers for drug delivery and increasing the acceptance of artificial implants, writes Carl Pichon.

Since many drugs cannot be delivered efficiently due to various obstacles such as low aqueous solubility and short half-life, designing a delivery system that makes the therapeutic agents show their highest possible healing process capacity is imperative, writes Ciara O'Sullivan.

Powder blending is one of the most critical unit operations in the pharmaceutical industry; however, it receives relatively little consideration in comparison to the more common unit operations such as distillation and heat exchange, writes Liam Meagher.

Intel Ireland senior software engineer Catriona Hewetson is working on software to enable the next generation of low power artificial intelligence hardware. She has spent most of the last 14 years working on low level software that enables new hardware accelerators (machine learning, cryptography, compression, etc.) to power future technologies. 

On the morning of February 16, 2020, a jogger running near the cliffs at Ballycotton in Co Cork made the first reported sighting of the cargo ship MV Alta since it had been encountered by the Royal Navy, adrift and derelict in the Atlantic the previous autumn.